AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data

CONCLUSION: Safety and efficacy of GL treatment using 0.1 mL (10 U) aboBoNT-A per injection site were demonstrated, with rapid onset and up to 6 months’ duration of effect. Severity improvement was accompanied by sustained aesthetic improvement and subject satisfaction. J Drugs Dermatol. 2021;20(9):988-995. doi:10.36849/JDD.6130.PMID:34491022 | DOI:10.36849/jdd.6130

Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Joel Schlessinger Daniel P Friedmann Flor Mayoral Deanne Mraz Robinson DeeAnna Glaser Douglas Wu Keith Marcus Michael Somenek Xiaoming Lin Source Type: research